Cortisol metabolism in human obesity: Impaired cortisone → cortisol conversion in subjects with central adiposity

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1022-1027

  Stewart, Paul M ^a   Boulton, Abigail ^a   Kumar, Sudhesh ^a   Clark, Penny M S ^b   Shackleton, Cedric H L ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; CORTISONE; CORTISONE ACETATE; DEXAMETHASONE; HYDROCORTISONE; INSULIN; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADULT; ARTICLE; AUTOCRINE EFFECT; BODY COMPOSITION; BODY FAT; BODY MASS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HORMONE ACTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; INSULIN RESISTANCE; MALE; METABOLIC ACTIVATION; METABOLIC BALANCE; METABOLIC REGULATION; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; STEROID METABOLISM;

EID: 0032990860     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.1022     Document Type: Article

References (43)

1. Björntorp P. 1997 Obesity. Lancet. 350:423-426.
2. Björntorp P. 1996 The regulation of adipose tissue distribution in humans. Int J Obes. 20:291-302.
3. Rebuffe-Scrive M, Krotkiewski M, Elfverson J, Björntorp P. 1988 Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab. 67:1122-1128.
4. Mayo-Smith W, Hayes CW, Biller BMK, Klibanski A, Rosenthal H, Rosenthal DI. 1989 Body fat distribution measured with CT: correlation in healthy subjects, patients with anorexia nervosa, and patients with Cushing's syndrome. Radiology 170:515-518.
5. Dunkelman SS, Fairhurst B, Plager J, Waterhouse C. 1964 Cortisol metabolism in obesity. J Clin Endocrinol Metab. 24:832-841.
6. Glass AR, Burman KD, Dahms WT, Boehm TM. 1981 Endocrine function in human obesity. Metabolism 30:89-104.
7. Hautenen A, Adlercreutz H. 1993 Altered adrenocorticotropin and Cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med. 234:461-469.
8. Ljung T, Amdersson B, Bengtsson B-A, Björntorp P. 1996 Inhibition of Cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res. 4:277-282.
9. Marin P, Darin N, Amemiya T, Anderson B, Jern S, Björntorp P. 1992 Cortisol secretion in relation to body fat distribution in obese pre-menopausal women. Metabolism. 41:882-886.
10. Migeon CJ, Green OC, Eckert JP. 1963 Study of adrenocortical function in obesity. Metabolism. 12:718-739.
11. Pasquali R, Cantobelli S, Casimirri F, et al. 1993 The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 77:341-346.
12. Streeteen DHP. 1993 Is hypothalamic-pituitary-adrenal hyperactivity important in the pathogenesis of excessive abdominal fat distribution? J Clin Endocrinol Metab. 77:339-340.
13. Stewart PM. 1996 11β-Hydoxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol (Oxf). 44:493-499.
14. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. 1994 Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 105:R11-R17.
15. Tannin GM, Agarwal AK, Monder C, New MI, White PC. 1991 The human gene for 11β-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem. 266:16653-16658.
16. White PC, Mune T, Agarwal AK. 1997 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev. 18:135-156.
17. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. 1988 Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest. 82:340-349.
18. Ricketts ML, Shoesmith KJ, Hewison M, Strain A, Eggo MC, Stewart PM. 1998 Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J Endocrinol. 156:159-168.
19. Ricketts ML, Verhaeg JM, Bujalska I, Howie A, Rainey WE, Stewart PM. Immunohistochemical localization of type. 1998 11β-Hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 83:1325-1335.
20. Yang K, Khalil MW, Strutt BJ, Killinger DW. 1997 11β-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol. 60:247-253.
21. Bujalska IJ, Kumar S, Stewart PM. 1997 Does central obesity reflect "Gushing's disease of the omentum?" Lancet. 349:1210-1213.
22. Shackleton CHL. 1993 Mass spectrometry in the diagnosis of steroid-related disorders and hypertension research. J Steroid Biochem Mol Biol. 45:127-140.
23. Palermo M, Shackleton CHL, Mantero F, Stewart PM. 1996 Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf). 45:605-611.
24. Stewart PM, Wallace AM, Atherden SM, Shearing C, Edwards CRW. 1990 Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone, and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci. 78:49-54.
25. Shams M, Kilby MD, Somerset DA, et al. 1998 11β-Hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod. 13:799-804.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985 Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412-419.
27. Ley CJ, Lees B, Stevenson JC. 1992 Sex-and menopause-associated changes in body fat distribution. Am J Clin Nutr. 55:950-954.
28. Phillipou G, Higgins BA. 1985 A new defect in the peripheral conversion of cortisone to Cortisol. J Steroid Biochem. 22:435-436.
29. Phillipov G, Palermo M, Shackleton CHL. 1996 Apparent cortisone reductase deficiency: a unique form of hypercortisolism. J Clin Endocrinol Metab. 81:3855-3860.
30. Zumoff B, Fukushima DK, Hellman L. 1974 Intercomparison of four methods for measuring Cortisol production. J Clin Endocrinol Metab. 38:169-175.
31. Rodin A, Thakkar H, Taylor N, Clayton R. 1994 Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med. 330:460-465.
32. Weaver JU, Taylor N, Monson JP, Wood PJ, Kelly WF. 1998 Sexual dimorphism in 11β-hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin Endocrinol (Oxf). 49:13-20.
33. Andrew R, Phillip DIW, Walker BR. 1998 Obesity and gender influence Cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 83:1806-1809.
34. Zumoff B, Bradlow HL, Levin J, Fukushima DK. 1983 Influence of thyroid function on the in vivo cortisol-cortisone equilibrium in man. J Steroid Biochem. 18:437-440.
35. Whorwood CB, Sheppard MC, Stewart PM. 1993 Tissue-specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase expression in the rat. J Steroid Biochem Mol Biol. 46:539-547.
36. Hammami MM, Siiteri PK. 1991 Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab. 73:326-334.
37. Jamieson P, Chapman KE, Edwards CRW, Seckl JR. 1995 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 136:4754-4761.
38. Kotelevtsev Y, Holmes MC, Burchell A, et al. 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity and stress. Proc Natl Acad Sci USA. 94:14924-14929.
39. Michael AE, Pester LA, Curtis P, Shaw RW, Edwards CRW, Cooke BA. 1993 Direct inhibition of ovarian steroidogenesis by Cortisol and the modulatory role of 11β-hydroxysteroid dehydrogenase. Clin Endocrinol (Oxf). 38:641-644.
40. Monder C, Miroff Y, Marandici A, Hardy M. 1994 11β-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocrinology. 134:1199-1204.
41. Whorwood CB, Sheppard MC, Stewart PM. 1993 Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology. 132:2287-2292.
42. Rajan V, Edwards CRW, Seckl JR. 1996 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci. 16:65-70.
43. Walker BR, Connacher AA, Lindsay M, Webb DJ, Edwards CRW. 1995 Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab. 80:3155-3159.